Although several risk factors in BCa have been documented [43], and high SIGLEC12 expression levels are shown in colorectal cancer [26] and renal cancer [27], the role of SIGLEC12 in BCa has not been documented. Here, SIGLEC12 is linked to renal carcinoma.